SCHEMBL8112759

SCHEMBL8112759

CC(C)(C)OC(=O)N1CCC(n2cc(-c3cccc(OCc4ccccc4)c3)c3c(N)ncnc32)CC1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 14/20 0.73
EGFR P00533 6/20 0.73
ABL1 P00519 4/20 0.73
ABL2 P42684 4/20 0.73
IGF1R P08069 9/20 0.71
INSR P06213 5/20 0.69
LYN P07948 4/20 0.69
ROCK2 O75116 3/20 0.69
LCK P06239 3/20 0.69
FGFR1 P11362 3/20 0.69
FLT4 P35916 3/20 0.69
KDR P35968 3/20 0.69
FLT3 P36888 3/20 0.69
AURKA O14965 2/20 0.69
CHEK2 O96017 2/20 0.69
CSF1R P07333 2/20 0.69
RPS6KB1 P23443 2/20 0.69
MARK3 P27448 2/20 0.69
CSNK1D P48730 2/20 0.69
BLK P51451 2/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11350290 0.90 IGF1R (0.77) SRCEGFRABL1ABL2IGF1R
SCHEMBL7018931 0.90 IGF1R (0.69) SRCEGFRABL1ABL2IGF1R
SCHEMBL8108104 0.89 SRC (0.91) SRCEGFRABL1ABL2LCK
SCHEMBL27469030 0.89 IGF1R (0.72) SRCEGFRABL1ABL2IGF1R
SCHEMBL8098919 0.88 SRC (0.90) SRCEGFRABL1ABL2RIPK2
SCHEMBL8098935 0.87 SRC (0.90) SRCEGFRABL1ABL2IGF1R
SCHEMBL8098846 0.85 SRC (0.75) SRCEGFRABL1ABL2IGF1R
SCHEMBL6462070 0.85 SRC (0.78) SRCEGFRABL1ABL2INSR
SCHEMBL30054291 0.85 SRC (0.78) SRCEGFRABL1ABL2INSR
SCHEMBL8108111 0.84 SRC (1.00) SRCEGFRABL1ABL2LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6051577-A TYROSINE INHIBITORS; BONE DISORDERS NOVARTIS AG (CH) 2000-04-18 US disclosed